Literature DB >> 10691927

Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE).

I Wichmann1, N Respaldiza, J R Garcia-Lozano, M Montes, J Sanchez-Roman, A Nuñez-Roldan.   

Abstract

Autoantibodies against the transcriptional DEK protein have been considered characteristic of the pauciarticular onset subtype of juvenile rheumatoid arthritis (JRA) associated with iridocyclitis in young girls. In this study we investigated the presence of anti-DEK autoantibodies in the sera of 288 patients with SLE using a recombinant DEK protein as autoantigenic target. Thirty sera (10.4%) were positive against DEK protein by immunoblotting. Patients with anti-DEK autoantibodies show a lower frequency of cutaneous manifestation, exhibit more frequently certain markers of a chronic inflammatory status like anaemia and positivity for C-reactive protein, as well as a higher frequency of anti-double-stranded DNA autoantibodies. In contrast to JRA patients positive for anti-DEK autoantibodies, no association with erosive arthritis nor iridocyclitis were found in SLE. In conclusion, our results show that 10.4% of SLE patients from our area show antibodies against DEK protein, although this feature did not clearly establish a clinical subset of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691927      PMCID: PMC1905599          DOI: 10.1046/j.1365-2249.2000.01154.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.

Authors:  G K Fu; G Grosveld; D M Markovitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.

Authors:  M von Lindern; M Fornerod; S van Baal; M Jaegle; T de Wit; A Buijs; G Grosveld
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

5.  Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis.

Authors:  X Dong; M A Michelis; J Wang; R Bose; T DeLange; W H Reeves
Journal:  Arthritis Rheum       Date:  1998-08

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis.

Authors:  H Sierakowska; K R Williams; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

8.  Autoantibodies to transcriptional regulation proteins DEK and ALY in a patient with systemic lupus erythematosus.

Authors:  I Wichmann; J R Garcia-Lozano; N Respaldiza; M F Gonzalez-Escribano; A Nuñez-Roldan
Journal:  Hum Immunol       Date:  1999-01       Impact factor: 2.850

9.  The lupus autoantigens and the pathogenesis of systemic lupus erythematosus.

Authors:  J A Hardin
Journal:  Arthritis Rheum       Date:  1986-04

10.  A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile rheumatoid arthritis.

Authors:  I S Szer; H Sierakowska; W Szer
Journal:  J Rheumatol       Date:  1994-11       Impact factor: 4.666

  10 in total
  11 in total

1.  Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes.

Authors:  Anita Krithivas; Masahiro Fujimuro; Magdalena Weidner; David B Young; S Diane Hayward
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Structure-specific binding of the proto-oncogene protein DEK to DNA.

Authors:  Tanja Waldmann; Martina Baack; Nicole Richter; Claudia Gruss
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

3.  Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.

Authors:  Ferdinand Kappes; Catalina Damoc; Rolf Knippers; Michael Przybylski; Lorenzo A Pinna; Claudia Gruss
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

4.  Functional domains of the ubiquitous chromatin protein DEK.

Authors:  Ferdinand Kappes; Ingo Scholten; Nicole Richter; Claudia Gruss; Tanja Waldmann
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 5.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

6.  Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Elizabeth E Jones; Kristen B Habash; Hiroshi Matsuo; Susanne I Wells
Journal:  Mol Cell Biol       Date:  2006-08-07       Impact factor: 4.272

7.  Expression and significance of tumor-related genes in HCC.

Authors:  Zi-Li Lü; Dian-Zhong Luo; Jian-Ming Wen
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

8.  The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Megan N Thobe; Elizabeth E Jones; Kristen B Habash; Karl Münger; Susanne I Wells
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.

Authors:  T McGarvey; E Rosonina; S McCracken; Q Li; R Arnaout; E Mientjes; J A Nickerson; D Awrey; J Greenblatt; G Grosveld; B J Blencowe
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

10.  The SAF-box domain of chromatin protein DEK.

Authors:  Friederike Böhm; Ferdinand Kappes; Ingo Scholten; Nicole Richter; Hiroshi Matsuo; Rolf Knippers; Tanja Waldmann
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.